Elm Partners Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Elm Partners Management's VRTX Position: Q2 2026 in Review
Elm Partners Management increased its Vertex Pharmaceuticals (VRTX) stake by 0.31% in Q2 2026, buying an estimated $886 and bringing the position to 638 shares worth $317K. The position accounts for 0.01% of the portfolio, ranked #129.
Elm Partners Management first reported a position in VRTX in Q3 2025 and has held it in 4 quarters since. 1,757 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Elm Partners Management held 638 shares of Vertex Pharmaceuticals worth $317K as of Q2 2026.
- Elm Partners Management bought 2 Vertex Pharmaceuticals shares in Q2 2026, an estimated $886.
- Vertex Pharmaceuticals made up 0.01% of Elm Partners Management's portfolio in Q2 2026, its #129 holding.
- Elm Partners Management first reported a position in Vertex Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
- 1,757 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Elm Partners Management's 13F filing for Q2 2026, filed 28 Jul 2026.